Research Ardvance in PLGA microspheres

Journal of China Pharmaceutical University

Volumn 38, Issue 2, 2007, Pages 186-189

  Chen, Ying Jie ^a,b   Xu, Xiang Yang ^a,b   Zhou, Jian Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Jiangsu Simcere Pharmaceutical R and D Co Ltd   (China)

Author keywords

Application; Burst release; Microspheres; PLGA; Preparation

Indexed keywords

MICROSPHERE; POLYGLACTIN;

BIODEGRADABILITY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG RESEARCH; DRUG SYNTHESIS; PARTICLE SIZE; REVIEW;

EID: 34248163009     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Gao P, Ding P, Xu H, et al. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly (D, L-lactide acid) and poly(D, L-lactide-co-glycolide acid) [J]. Chem Pharm Bull (Tokyo),2006, 54(1):89-93.
2. Andrieu-Soler C, Aubert-Pouessel A, Doat M, et al. Intravitreous injection of PLGA microspheres encapsulating gdnf promotes the survival of photoreceptors in the rd1/rd1 mouse[J]. Mol Vis,2005, 11:1 002-1 011.
3. Gavini E, Chetoni P, Cossu M, et al. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/ spray-drying as the preparation method: in vitro/in vivo studies[J]. Eur J Pharm Biopharm,2004,57(2):207-212.
4. Genentech patient information letter, June 2004. http://www.nutropin.com/ patient/1 9 nutropin depot.jsp.
5. Zidan AS, Sammour OA, Hammad MA, et al. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers [J]. AAPS Pharm Sci Tech,2006,7(3):61.
6. Makino K, Nakajima T, Shikamura M, et al. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin[J]. Colloid Surf B Biointerfaces, 2004, 36(1):35-42.
7. Tomoda K, Kojima S, Kajimoto M, et al. Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres[J]. Colloids Surf B Biointerfaces, 2005,45(1):1-6.
8. Armstrong DK, Fleming GF, Markman M, et al. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (paclimer) in recurrent ovarian cancer: a gynecologic oncology group study[J]. Gynecol Oncol,2006,103(2):391-396.
9. Gupte A, Ciftei K. Formulation and characterization of paclitaxel, 5-fu and paclitaxel + 5-fu microspheres[J]. Int J Pharm, 2004,276 (1-2):93-106.
10. Cheng J, Chi Q, Qie J, et al. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist[J]. Chem Pharm Bull (Tokyo), 2006,54(9):1 259-1 265.
11. Sapin A, Garcion E, Clavreul A, et al. Development of new polymer-based particulate systems for anti-glioma vaccination[J]. Int J Pharm, 2006,309(1-2):1-5.
12. Feng L, Qi XR, Zhou XJ, et al. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres[J]. J Control Release,2006,112(1):35-42.
13. Klose D, Siepmann F, Elkharraz K, et al. How porosity and size affect the drug release mechanisms from PLGA-based microparticles [J]. Int J Pharm, 2006,314(2):198-206.
14. Zheng CH, Gao JQ, Liang WQ, et al. Effects of additives and processing parameters on the initial burst release of protein from poly (lactic-co-glycolic acid) microspheres [J]. PDA J Pharm Sci Technol. 2006,60(1):54-59.
15. Fernandez-Carballido A, Puebla P, Herrero-Vanrell R, et al. Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiation[J]. Int J Pharm,2006,313(1-2):129-135.